TRAVADE - CAP DIN 02168030
Health Canada record
| Active ingredient(s) | CLOVE OIL 0.01 ML; PEPPERMINT OIL 0.006 ML; CINNAMON OIL 0.01 ML; GINGER 100 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1995 |
| Current status date | 08-Sep-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamieson Laboratories Ltd. — licence 100166, currently licensed, last inspection rating C (2022-05-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOVE OIL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02240291 | AMOL | AMOL PHARMA GMBH | Liquid | CLOVE OIL 0.1 %; CINNAMON OIL 0.24 %; PEPPERMINT OIL 1.963 %; LAVENDER OIL 0.24 % | Cancelled Post Market |
| 00179752 | CLOVE OIL | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | Liquid | CLOVE OIL 100 % | Cancelled Post Market |
| 00539872 | LIN O GEL | HAWTHORNE PRODUCTS INC. | Ointment | CLOVE OIL 2.7 G; THYMOL 1.2 G; ISOPROPYL ALCOHOL 60 G; CAMPHOR 4.8 G; MENTHOL 3.7 G; IODINE 3.7 G; TURPENTINE 3.2 G | Cancelled Post Market |
International API supply for CLOVE OIL
1 active FDA Drug Master Files.
Request a quote for TRAVADE - CAP